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MEDIA RELEASE
October 29, 1986
UM BIOCHEMIST RECEIVES $226,000 IN RESEARCH 
FUNDS FROM NATIONAL INSTITUTES OF HEALTH
MISSOULA —
University of Montana chemistry professor Walter Hill has 
just received $226,000 to continue studying some of life's most 
closely-held secrets. The three-year grant comes from the 
National Institutes of Health (NIH), a federal agency which, 
along with the National Science Foundation (NSF), has funneled 
over 1.5 million dollars into Hill’s research during his career 
at the University of Montana.
What is Hill studying that warrants such support? His 
research centers on ribosomes, the tiny, double-bodied homes to 
strings of ribonucleic acid (RNA) and proteins. The ribosomes 
take genetic blueprints from the deoxyribose nucleic acid (DNA, 
the substance of genes) and manufacture proteins for the body 
according to their directions. But how the ribosomes make that 
transition from communicating to manufacturing is still a 
mystery. Unlocking that mystery holds implications for major 
breakthroughs in diagnostic medicine, cancer research and 
immunology.
Hill and his fellow scientists and researchers know the 
secrets to the communication and manufacturing processes lie in 
the way that ribosomes bond with various kinds of RNA. He
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explains that some RNA contains all the genetic information cells 
need to function. DNA initially transfers this information to 
RNA, which in turn takes it to the ribosome where the message is 
decoded and protein is made.
It's something like using different languages and alphabets, 
Hill says. Messenger-RNA (the main communicator of the genetic 
message), and DNA have only four letters in a particular 
"biological alphabet" to use. But the proteins, which are the 
ultimate product, contain as many as 20 letters (amino acids) in 
what is essentially a different biological language. The 
ribosome serves as the translation device.
But in human biology, of course, glitches in translation can 
and do occur. For example, Hill knows that the way bonding 
occurs between the RNA and ribosomes in a person who is ill may 
not be the same as the bonding in a healthy individual. And he 
knows that deliberate intervention in this bonding process has 
already provided massive medical benefits to mankind in the form 
of antibiotics, which work at the bonding sites themselves.
These bonding sites or "nests," within the ribosomes serve 
as bonding locations for various kinds of RNA. Antibiotics 
interfere in the nests, stopping the ribosomes from working, and 
effectively canceling cell growth, slowing or halting the course 
of an infection. Because interfering with bonding can cancel 
cell growth, Hill says the implications for finding a cure for 
cancer are also strong.
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Hill and his research team know they can prevent protein 
manufacture entirely in a laboratory simulation. For example, 
they can synthesize small pieces of DNA in their lab at the 
university and cover a loop or ’’nest” site on one of the 
ribosome's sub-units with these DNA strings. The DNA cover 
prevents the loop, which is looking for its answering site on the 
other part of the ribosome, from finding its match and joining 
with it. Removing the DNA pieces leaves the loop clear once 
again; the two halves of the ribosome bond through the loop and 
the ribosome is again functional.
A different protein-RNA link recently made national 
headlines when scientists at Children's Hospital in Boston and 
Harvard Medical School reported the discovery of the gene 
responsible for Duchenne muscular dystrophy, a progressive 
disease that destroys muscle tissue.
The culprit gene serves as the blueprint for the manufacture 
of a specific protein in muscle tissue. When that protein is 
missing or altered, Duchenne muscular dystrophy results. The 
scientists found that the gene produced messenger-RNA that would 
direct the formation of the protein chain. The garbled genetic 
code inserted a faulty amino acid into the protein chain, causing 
the protein to either not be created at all or to be altered.
Hill has been fascinated with ribosomes since his graduate 
student days at the University of Wisconsin-Madison. In addition 
to the funding he has received from NIH and NSF, he has also
more
received NIH pre-doctoral and post-doctoral fellowships as well 
as an NIH Research Career Development Award.
Hill collaborates with scientists world-wide in the course 
of his research. In September he traveled to the Soviet Union at 
the invitation of the Soviet Academy of Sciences to present his 
work. He also collaborates with scientists at the University of 
Texas, Yale and UCLA as well as scientists in Moscow and Berlin.
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